When federal lawmakers legalized hemp last year, they opened the floodgates to hundreds of companies focused largely on a single molecule in the plant: cannabidiol, or CBD. Now, with thousands of products on the market, from infused enemas to espresso, the US Food and Drug Administration (FDA) is preparing to craft regulations around the cannabinoid. […]